Recombinant human interleukin-2 (rhIL-2)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human interleukin-2 (rhIL-2), covering 2012-05-21 to 2012-05-21. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone [Phase 2]